Joshua Rosenblat

Chief Tech/Sci/R&D Officer at CHAMPIGNON BRANDS

Consumer Services

Finance

Health Technology

Profile

Joshua Rosenblat is the founder of 1907 Foundation.
He is currently working as an Assistant Professor at the University of Toronto, a Clinical & Technical Advisor at iGan Partners, and as the Chief Medical & Scientific Officer at Braxia Scientific Corp.
He completed his undergraduate degree at the University of Toronto and his doctorate at the University of Western Ontario.

Joshua Rosenblat active positions

Companies	Position	Start
CHAMPIGNON BRANDS	Chief Tech/Sci/R&D Officer	28/05/2021
iGan Partners iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments.	Consultant / Advisor	-
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
1907 Foundation	Founder	-

All active positions of Joshua Rosenblat

Training of Joshua Rosenblat

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joshua Rosenblat's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Western Ontario University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
iGan Partners iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments.	Finance
Braxia Scientific Corp. Braxia Scientific Corp. BiotechnologyHealth Technology Develops ketamine treatment and psychedelic medicine for mental health treatments	Health Technology
1907 Foundation